China SXT Pharmaceuticals Inc.

SXTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.47

+$0.09 (+3.78%)

At close: Sep 22, 2026, 4:00 PM ET

$2.45

-$0.02 (-0.81%)

After-hours: Sep 22, 2026, 7:48 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.27M

Enterprise Value $-25.8M

Beta 1.84

Average Volume 672.48K

Shares Outstanding (Diluted) 585.77K

Shares Change YoY -76.02%

Institutional Ownership 0.14%

Exchange NASDAQ

ISIN VGG2161P1734

Price Performance

Price Change 1M -40.8%

Price Change 3M -98.8%

Price Change 6M -97.8%

Price Change YTD -100.0%

Price Change 1Y -100.0%

Price Change 3Y -100.0%

Price Change 5Y -100.0%

1M CAGR (ann.) -34.6%

1Y CAGR (ann.) -100.0%

5Y CAGR (ann.) -96.6%

All-Time CAGR -92.5%

Valuation

PE Ratio -0.30

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio 0.60

Forward PS N/A

PB Ratio 0.04

P/FCF Ratio -0.24

P/Adj. FCF Ratio -0.25

P/OCF Ratio -0.22

EV/Sales -12.40

EV/EBIT 3.43

EV/EBITDA 3.51

EV/FCF 5.01

Earnings Yield -338.3%

FCF Yield -410.4%

Adj. FCF Yield -395.7%

Financial Health

Net Cash $27.11M

Total Debt $1.12M

Cash & Short-Term Investments $28.18M

Total Assets $34.75M

Current Ratio 7.93

Quick Ratio 7.25

Debt / Equity Ratio 0.04

Debt / EBITDA -0.15

Debt / FCF -0.22

OCF / Debt -4.59

Interest Coverage -27.39

Altman Z-Score -0.84

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 44.4%

Operating Profit Margin -361.2%

EBITDA Margin -329.8%

Net Profit Margin -290.7%

FCF Margin -247.5%

Adj. FCF Margin -238.6%

SBC / Revenue -7.3%

SBC Impact (per share) -3.6%

Returns

Return on Assets -21.2%

Return on Equity -31.0%

Return on Invested Capital -23.3%

Return on Capital Employed -28.1%

Return on Tangible Assets -21.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -32.2%

Revenue CAGR 5Y -21.5%

Revenue CAGR 10Y -11.7%

EPS CAGR 3Y 67.1%

EPS CAGR 5Y 78.2%

EPS CAGR 10Y -0.9%

FCF CAGR 3Y -57.0%

FCF CAGR 5Y -41.8%

FCF CAGR 10Y -38.3%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Jul 29, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-5.15M

Free Cash Flow $-5.15M

Adj. Free Cash Flow $-4.97M

FCF Per Share -$8.79

OCF Per Share -$10.48

OCF/S Ratio -242.0%

Income Statement

Revenue $2.08M

Gross Profit $1.01M

Operating Income $-7.51M

EBITDA $-7.35M

Net Income $-6.12M

EPS (Diluted) -$7.95

Revenue / Employee $37.16K

Profit / Employee $-109.34K

Employees 56